The Net Margin of Allogene Therapeutics Inc (ALLO) is -1170863.70%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-12-31 | -1170863.70% |
| 2023-12-31 | -344489.48% |
| 2022-12-31 | -138595.83% |
| 2021-12-31 | -667.73% |